RyR2 and Calcium Release in Heart Failure.

Area of Science:

• Cardiology
• Molecular Biology
• Physiology

Background:

• Heart failure (HF) is characterized by the heart's inability to meet the body's circulatory demands.
• Dysfunctional calcium (Ca2+) handling is a key contributor to impaired cardiac contraction and relaxation in HF.
• The sarcoplasmic reticulum (SR) Ca2+ release channel, type 2 ryanodine receptor (RyR2), plays a critical role in cardiac Ca2+ cycling.

Purpose of the Study:

• This review focuses on alterations in RyR2 function and its contribution to the pathophysiology of heart failure.
• To explore the impact of RyR2 modifications on cardiac contractility and arrhythmogenesis in HF.
• To discuss recent findings in both HF with reduced and preserved ejection fraction.

Main Methods:

• Literature review of experimental and clinical studies on RyR2 in heart failure models.
• Analysis of research investigating RyR2 phosphorylation, oxidation, and protein interactions.
• Examination of studies on structural remodeling affecting RyR2 function.

Main Results:

• HF is associated with reduced RyR2 responsiveness to L-type calcium channel activation due to cardiomyocyte remodeling.
• Enhanced RyR2 phosphorylation (e.g., at S2814) and oxidation are observed in human and experimental HF.
• Diminished FKBP12.6 expression and altered RyR2 function may contribute to contractile dysfunction and arrhythmias.

Conclusions:

• Alterations in RyR2 are central to the diminished cardiac function seen in heart failure.
• Modified RyR2 function contributes to both reduced contractility and increased susceptibility to arrhythmias in HF.
• RyR2 dysfunction may also underlie supraventricular defects, including sinus node dysfunction and atrial fibrillation, in HF patients.